RSV Vaccine

About

The RSV vaccine is designed to protect against respiratory syncytial virus (RSV), a common cause of respiratory illnesses. RSV can lead to severe conditions like pneumonia and bronchiolitis, particularly in infants and older adults. The vaccine is recommended for pregnant women to provide protection to their newborns during the first six months of life. It is also recommended for older adults, especially those aged 75 and older, to prevent serious RSV infections. The RSV vaccine is administered as a single dose and can be given at any time, though it is most beneficial before the RSV season. Pregnant women typically receive the vaccine between 32 and 36 weeks of gestation. Older adults may receive it alongside other vaccines, such as flu or pneumococcal vaccines. The vaccine helps reduce the risk of hospitalization due to RSV and is crucial for individuals with underlying health conditions like COPD or heart disease.